It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines ...

A phylogenetic tree of SARS-CoV-2 sequences, built with Nextstrain, displays sequences colored by their clade and organized by collection date. Over time, sequences mutate and diverge, forming new ...

Viruses like SARS-CoV-2 use sugar molecules to hide from the immune system, but scientists at Scripps Research have designed ...

Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors.

This article explores how automation is transforming proteomics by streamlining proteoform analysis, boosting throughput and ...

Sugar coatings aren't only for candies; they also help viruses, like the ones that cause COVID-19, hide from their hosts' ...

Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect ...

SNGX READ THE FULL SNGX RESEARCH REPORT Business Update CiVax™ Booster Enhances Protection from COVID-19 in NHPs On March 25, ...

Identification of HKU5-CoV-2 (a member of the HKU5 lineage 2), a new merbecovirus found in bats of Zhejiang, Anhui, and ...